PARP Inhibitors: A Novel Mechanism to Overcome Resistance in Aggressive HER2+Breast Cancers

Grant

Date/time Interval

  • November 1, 2018 - November 1, 2021
  • Total Award Amount

  • 600000.00
  • Direct Costs

  • 545454.00
  • Sponsor Award Id

  • T2018-005
  • Contributor

  • Stringer-Reasor M.D., Erica   Principal Investigator